Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Acquity Group Currently Estimates IPO Price To Be $8.00-$10.00/ADS - Quick Facts

Digital advertiser Acquity Group Ltd. said it now estimates the initial public offering price to be between $8.00 and $10.00 per ADS. The company is offering 9.56 million of its ordinary shares in the form of ADSs and the selling shareholders named in the prospectus are selling 1.56 million ordinary shares in the form of ADSs.

Acquity Group noted that it will not receive any proceeds from the sale of the ADSs by the selling shareholders. The ADSs may be evidenced by American depositary receipts, or ADRs, and each ADS represents two ordinary shares, par value $0.0001 per ordinary share.

Acquity Group has applied to have the ADSs listed on the New York Stock Exchange, or the NYSE, under the symbol "AQ".

Click here to receive FREE breaking news email alerts for Acquity Group Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
United Nations Secretary-General Ban Ki-moon on Tuesday urged both Israelis and Palestinians to stop the fighting that has been raging for the past two weeks in the Gaza Strip, and pleaded with the two sides to return to dialogue with the aim of addressing the underlying causes of the repeated cycles... After moving notably higher in early trading on Tuesday, stocks continued to perform well throughout the session. The gains on the day offset the modest weakness that was seen in the previous session, extending the recent back-and-forth movement by the markets. Two federal appeals courts have issued contradictory rulings over the federal government's ability to provide subsidies under Obamacare, suggesting that the future of President Barack Obama's healthcare law could once again end up in the hands of the U.S. Supreme Court.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.